Conditions
You're more than a diagnosis, this is your full picture.
You are not imagining this
The conditions on this page disproportionately affect women , and many of us were told for years that the pain, the flares, the cycles we lived through were normal, or in our heads. They are not. They are real, they are hormonally driven, and there is research behind every word that follows.
Your conditions
Pick the conditions you actually live with. Keza will use this to filter every insight, herb recommendation, medication warning, and pattern detection , not generic advice.
Don't see your condition? Add it.
Keza will save it to your profile and pull peer-reviewed research, clinical trials, and clinician-reviewed sources for it, across your sleep, stress, and log pages too.
Select your condition. Keza will show you exactly how your hormones are driving it, phase by phase, week by week.
The prevalence numbers, diagnostic delays, and disparities flagged on these conditions come from these peer-reviewed sources. Tap any source to read it on PubMed.
Cochrane systematic review - exercise for menopausal symptoms
Cochrane review of RCTs on exercise interventions for vasomotor symptoms, mood, sleep, and quality of life in menopausal women. Exercise showed modest improvements in quality of life and mood. Evidence for hot flash reduction specifically was inconclusive. Exercise remains strongly recommended due to cardiovascular, bone, and mood benefits with low risk profile.
2023 International evidence-based guideline for the assessment and management of polycystic ovary syndrome
International evidence-based guideline on PCOS from the International PCOS Network involving 39 organisations and 6,000 women with lived experience. Updated recommendations on PCOS diagnosis, screening for metabolic and psychological comorbidities, lifestyle management as first-line treatment, and pharmacological options. Recognises significant ethnic variation in PCOS presentation and emphasises psychological wellbeing as a core management component.
Specialized pro-resolving lipid mediators and dietary omega-3 fatty acids in selected inflammatory skin diseases including hidradenitis suppurativa - systematic review
Systematic review covering omega-3 fatty acids and specialized pro-resolving mediators in inflammatory skin diseases including hidradenitis suppurativa. Preclinical data consistently demonstrates that omega-3-derived mediators modulate key inflammatory pathways relevant to HS. Human studies show altered lipid mediator profiles in HS patients characterised by reduced omega-3-derived anti-inflammatory compounds. Evidence supports omega-3 supplementation as a low-risk adjunct to HS management.
High Cumulative Incidence of Uterine Leiomyoma in Black and White Women: Ultrasound Evidence
Ultrasound screening found >80% of Black women and ~70% of White women had fibroids by age 50; Black women were affected earlier and more severely.
Patient Perceptions of Misdiagnosis of Endometriosis: Results from an Online National Survey
Mean diagnostic delay for endometriosis in the US is 6.7 years; 75% of affected women in this national survey were initially misdiagnosed.
Racial and Ethnic Disparities in Polycystic Ovary Syndrome
Black and Hispanic women with PCOS carry greater metabolic burden and face systematic underdiagnosis compared to White women.
Race-Specific Prevalence of Hidradenitis Suppurativa
Black patients have a disproportionately high prevalence of hidradenitis suppurativa in the US relative to population share.
Genitourinary Syndrome of Menopause: A Systematic Review on Prevalence and Treatment
GSM affects 27–84% of postmenopausal women; unlike hot flashes it does not resolve without treatment; highly effective low-risk local therapies exist.
Hysterectomy Among Women Age 18 and Older: United States, 2021
Non-Hispanic Black women had the highest hysterectomy prevalence of any racial/ethnic group in the 2021 National Health Interview Survey; non-Hispanic Asian women the lowest.